Noile-Immune Biotech Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	6,539	5,759	7,361	9,175	-	-
Market Cap Growth	-9.58%	-21.77%	-19.77%	-	-	-
Enterprise Value	2,621	1,641	2,645	3,519	-	-
Last Close Price	151.00	133.00	170.00	212.00	-	-
PS Ratio	1307.71	1151.83	1051.61	29.03	-	-
PB Ratio	1.66	1.47	1.56	1.61	-	-
P/TBV Ratio	1.66	1.47	1.56	1.61	-	-
EV/Sales Ratio	-	328.23	377.90	11.14	-	-
Net Debt / Equity Ratio	-1.00	-1.00	-0.99	-0.98	-1.05	-0.99
Asset Turnover	0.00	0.00	0.00	0.06	0.14	0.03
Inventory Turnover	10.40	10.40	4.86	3.65	2.00	3.14
Quick Ratio	53.30	53.30	68.58	65.36	13.49	52.41
Current Ratio	53.82	53.82	69.20	66.48	13.68	52.81
Return on Equity (ROE)	-18.32%	-18.32%	-18.52%	-22.63%	-9.10%	-23.44%
Return on Assets (ROA)	-11.31%	-11.31%	-12.63%	-9.31%	-1.49%	-13.79%
Return on Capital Employed (ROCE)	-20.20%	-20.20%	-22.60%	-13.60%	-2.50%	-18.30%
Earnings Yield	-12.13%	-13.77%	-13.10%	-12.32%	-	-
Buyback Yield / Dilution	-0.01%	-0.01%	-4.41%	-5.87%	-2.23%	-7.89%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.